Amplified ferroptosis and immunomodulation triggered by NIR-II photothermal-controllable CRISPR/Cas9 nanoplatform to treat osteosarcoma and prevent postsurgical implant-associated infections

Biomaterials 2026

View at publisher

Authors: Mingfei Li, Mingfei Li, Liuliang He, Long Wang, Long Wang, Qiyong Pan, Pengfei Sun, Daifeng Li, Chi Zhang

DOI: 10.1016/j.biomaterials.2026.124043

Cited by: 1

References: 55

Fields of Study & Subjects

Ferroptosis and cancer prognosis interferon and immune responses Nanoplatforms for cancer theranostics

References 55